Cancer-related condition
MONDO:0045054A disorder either associated with an increased risk for malignant transformation (e.g., intraepithelial neoplasia, leukoplakia, dysplastic nevus, myelodysplastic syndrome) or that develops as a result of the presence of an existing malignant neoplasm (e.g., paraneoplastic syndrome).
Also known as: cancer related problem/condition, cancer-related condition, cancer-related problem or condition, oncologic complications, problem/condition, cancer related, problem/condition, cancer-related
36 clinical trials for this condition and its sub-types, 16 tagged with Cancer-related condition itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Cancer-related condition
-
Paraneoplastic syndrome 1 trial · 20 incl. sub-types
8 sub-types
- Paraneoplastic neurologic syndrome 1 trial · 15 incl. sub-types Sub-types →
- Parneoplastic endocrine syndrome 0 trials · 11 incl. sub-types Sub-types →
- Paraneoplastic hematological syndrome 0 trials · 9 incl. sub-types Sub-types →
- Paraneoplastic renal syndrome 0 trials · 3 incl. sub-types Sub-types →
- Bilateral diffuse uveal melanocytic proliferation disease 0 trials
- Paraneoplastic cutaneous syndrome 0 trials Sub-types →
- Paraneoplastic gastrointestinal syndrome 0 trials
- Paraneoplastic rheumatic syndrome 0 trials
-
Gastric linitis plastica 0 trials
Most studied deeper sub-types
-
New pill aims to boost red blood cells in cancer patients
Symptom relief Not yet recruitingThis Phase 2 trial tests an oral drug called AND017 for anemia (low red blood cells) in cancer patients who are not receiving chemotherapy. The study will enroll 36 participants to see if different doses of AND017 can safely raise hemoglobin levels over 6 weeks. The goal is to re…
Phase 2 • Sponsor: Kind Pharmaceuticals LLC • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can a new injection stop the wasting of cancer cachexia?
Symptom relief Not yet recruitingThis early-stage trial is testing an experimental drug called QLS2319 for cancer cachexia — the severe weight loss and muscle wasting that can happen with advanced cancer. The study first gives a single dose to healthy volunteers to check safety, then gives multiple doses to peop…
Phase 1/2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can remote check-ins and telehealth improve quality of life for advanced cancer patients?
Symptom relief Not yet recruitingThis trial tests a program that combines palliative care with remote monitoring and telehealth to better support people with advanced cancer. Participants complete questionnaires and physical exams, and their care is tailored to their needs. The study includes 300 adults with met…
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC